q&a: financial or location limitations to bispecific antibody treatments? -blood cancer onctalk 2023
Published 5 months ago • 13 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
3:53
the future of bispecific antibodies - blood cancer onctalk 2023
-
1:56
types of bispecific antibodies - blood cancer onctalk 2023
-
1:37
pros and cons of bispecific antibodies - blood cancer onctalk 2023
-
2:53
management of bispecific antibodies side effects - blood cancer onctalk 2023
-
3:56
bispecific antibodies in myeloma: approvals and clinical trials - blood cancer onctalk 2023
-
2:39
q&a: bispecific treatment in lymphoma: key doctor discussions - blood cancer onctalk 2023
-
3:49
q&a: how do oncologists determine treatment orders? - blood cancer onctalk 2023
-
3:44
bispecific antibodies in lung cancer - onctalk lung 2023
-
1:05
q&a: does bispecific treatment for lymphoma affect fertility? - blood cancer onctalk 2023
-
5:48
teclistamab, talquetamab, and elranatamab: response rates and data - blood cancer onctalk 2023
-
3:53
identifying smoldering multiple myeloma patients: risk factors - blood cancer onctalk 2023
-
1:31
are there any ongoing trials for acute leukemia in adults? - blood cancer onctalk
-
2:26
risk adaptive management for high risk multiple myeloma - blood cancer onctalk
-
2:14
q&a: what are costs and side effects of antibody drug conjugates? - onctalk lung 2023
-
1:55
how do i find clinical trials? - blood cancer onctalk
-
2:52
location of disease: can metastatic locations predict success of treatment? - onctalk 2022
-
2:24
is there a way to alleviate the cost of car t-cell therapies? - blood cancer onctalk
-
2:40
identifying individuals at higher risk of breast cancer - the importance of testing 2023
-
6:43
what factors determine a successful clinical trial? - lung cancer onctalk 2022